440 related articles for article (PubMed ID: 25850036)
41. APC/C(Cdh1)-dependent degradation of Cdc20 requires a phosphorylation on CRY-box by Polo-like kinase-1 during somatic cell cycle.
Hyun SY; Sarantuya B; Lee HJ; Jang YJ
Biochem Biophys Res Commun; 2013 Jun; 436(1):12-8. PubMed ID: 23643811
[TBL] [Abstract][Full Text] [Related]
42. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities.
Stegmeier F; Rape M; Draviam VM; Nalepa G; Sowa ME; Ang XL; McDonald ER; Li MZ; Hannon GJ; Sorger PK; Kirschner MW; Harper JW; Elledge SJ
Nature; 2007 Apr; 446(7138):876-81. PubMed ID: 17443180
[TBL] [Abstract][Full Text] [Related]
43. The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review.
Xian F; Zhao C; Huang C; Bie J; Xu G
Medicine (Baltimore); 2023 Sep; 102(36):e35038. PubMed ID: 37682144
[TBL] [Abstract][Full Text] [Related]
44. Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.
Li J; Gao JZ; Du JL; Huang ZX; Wei LX
Int J Oncol; 2014 Oct; 45(4):1547-55. PubMed ID: 25069850
[TBL] [Abstract][Full Text] [Related]
45. Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors.
Bhuniya R; Yuan X; Bai L; Howie KL; Wang R; Li W; Park F; Yang CY
ACS Med Chem Lett; 2022 Feb; 13(2):188-195. PubMed ID: 35178174
[TBL] [Abstract][Full Text] [Related]
46. Insights into APC/C: from cellular function to diseases and therapeutics.
Zhou Z; He M; Shah AA; Wan Y
Cell Div; 2016; 11():9. PubMed ID: 27418942
[TBL] [Abstract][Full Text] [Related]
47. The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors.
Wu F; Sun Y; Chen J; Li H; Yao K; Liu Y; Liu Q; Lu J
Front Oncol; 2021; 11():721797. PubMed ID: 34527589
[TBL] [Abstract][Full Text] [Related]
48. CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer.
Wu WJ; Hu KS; Wang DS; Zeng ZL; Zhang DS; Chen DL; Bai L; Xu RH
J Transl Med; 2013 Jun; 11():142. PubMed ID: 23758705
[TBL] [Abstract][Full Text] [Related]
49. Discovery of Ureido-Based Apcin Analogues as Cdc20-specific Inhibitors against Cancer.
He Y; Le X; Hu G; Li Q; Chen Z
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259447
[TBL] [Abstract][Full Text] [Related]
50. Emerging roles of F-box proteins in cancer drug resistance.
Yan L; Lin M; Pan S; Assaraf YG; Wang ZW; Zhu X
Drug Resist Updat; 2020 Mar; 49():100673. PubMed ID: 31877405
[TBL] [Abstract][Full Text] [Related]
51. The emerging role of WWP1 in cancer development and progression.
Hu X; Yu J; Lin Z; Feng R; Wang ZW; Chen G
Cell Death Discov; 2021 Jun; 7(1):163. PubMed ID: 34226507
[TBL] [Abstract][Full Text] [Related]
52. Structure-based virtual screening for identification of potential CDC20 inhibitors and their therapeutic evaluation in breast cancer.
Das A; Sharma HK; Lather V; Pandita D; Agarwal P
3 Biotech; 2023 May; 13(5):141. PubMed ID: 37124982
[TBL] [Abstract][Full Text] [Related]
53. CDC20-Mediated hnRNPU Ubiquitination Regulates Chromatin Condensation and Anti-Cancer Drug Response.
Wavelet-Vermuse C; Odnokoz O; Xue Y; Lu X; Cristofanilli M; Wan Y
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954396
[TBL] [Abstract][Full Text] [Related]
54. CDC20 Knockdown and Acidic Microenvironment Collaboratively Promote Tumorigenesis through Inhibiting Autophagy and Apoptosis.
Gu Q; Li F; Ge S; Zhang F; Jia R; Fan X
Mol Ther Oncolytics; 2020 Jun; 17():94-106. PubMed ID: 32322666
[TBL] [Abstract][Full Text] [Related]
55. The Emerging Role of Sperm-Associated Antigen 6 Gene in the Microtubule Function of Cells and Cancer.
Zheng DF; Wang Q; Wang JP; Bao ZQ; Wu SW; Ma L; Chai DM; Wang ZP; Tao YS
Mol Ther Oncolytics; 2019 Dec; 15():101-107. PubMed ID: 31660426
[TBL] [Abstract][Full Text] [Related]
56. The Function and Regulation of SAPCD2 in Physiological and Oncogenic Processes.
Baker AL; Du L
J Cancer; 2022; 13(7):2374-2387. PubMed ID: 35517423
[TBL] [Abstract][Full Text] [Related]
57. Releasing the brake on presynaptic development: Cdc20-APC triggers NeuroD2 degradation to drive presynaptic differentiation.
Yang Y; Bonni A
Cell Cycle; 2010 Jun; 9(12):2255-6. PubMed ID: 20699636
[No Abstract] [Full Text] [Related]
58. Correction: CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.
Mitsui Y; Chang I; Fukuhara S; Hiraki M; Arichi N; Yasumoto H; Hirata H; Yamamura S; Shahryari V; Deng G; Wong DK; Majid S; Shiina H; Dahiya R; Tanaka Y
BMC Cancer; 2022 Jul; 22(1):813. PubMed ID: 35879687
[No Abstract] [Full Text] [Related]
59. CDC20 maintains tumor initiating cells.
Xie Q; Wu Q; Mack SC; Yang K; Kim L; Hubert CG; Flavahan WA; Chu C; Bao S; Rich JN
Oncotarget; 2015 May; 6(15):13241-54. PubMed ID: 25938542
[TBL] [Abstract][Full Text] [Related]
60. Cdc20: At the Crossroads between Chromosome Segregation and Mitotic Exit.
Kapanidou M; Curtis NL; Bolanos-Garcia VM
Trends Biochem Sci; 2017 Mar; 42(3):193-205. PubMed ID: 28202332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
